Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

N. Von Bubnoff; C. Rummelt; H. Menzel; M. Sigl; C. Peschel; J. Duyster

doi:10.1038/leu.2010.122

Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

N. Von Bubnoff^*, C. Rummelt, H. Menzel, M. Sigl, C. Peschel, J. Duyster

^*Korrespondierende/r Autor/-in für diese Arbeit

Klinik für Hämatologie und Onkologie

Technische Universität München

19 Zitate (Scopus)

Originalsprache	Englisch
Zeitschrift	Leukemia
Jahrgang	24
Ausgabenummer	8
Seiten (von - bis)	1523-1525
Seitenumfang	3
ISSN	0887-6924
DOIs	https://doi.org/10.1038/leu.2010.122
Publikationsstatus	Veröffentlicht - 08.2010

Fördermittel

Institut National du Cancer. This work was supported by grants from the Ligue Nationale Contre le Cancer (équipe labelisée 2009). This letter is dedicated to Sabrina Dupont whose work greatly contributed to the discovery of TET2 mutations in MPNs. This work was supported by Bundesministerium für Bildung und Forschung grant NGFNplus 01GS0878.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Dokumente

10.1038/leu.2010.122

Weitere Links

Link to publication in Scopus

Zitieren

@article{d3ff5aee767242d08cb349778599a344,

title = "Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib",

author = "\{Von Bubnoff\}, N. and C. Rummelt and H. Menzel and M. Sigl and C. Peschel and J. Duyster",

note = "Funding Information: Institut National du Cancer. This work was supported by grants from the Ligue Nationale Contre le Cancer ({\'e}quipe labelis{\'e}e 2009). This letter is dedicated to Sabrina Dupont whose work greatly contributed to the discovery of TET2 mutations in MPNs. Funding Information: This work was supported by Bundesministerium f{\"u}r Bildung und Forschung grant NGFNplus 01GS0878.",

year = "2010",

month = aug,

doi = "10.1038/leu.2010.122",

language = "English",

volume = "24",

pages = "1523--1525",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

AU - Von Bubnoff, N.

AU - Rummelt, C.

AU - Menzel, H.

AU - Sigl, M.

AU - Peschel, C.

AU - Duyster, J.

N1 - Funding Information: Institut National du Cancer. This work was supported by grants from the Ligue Nationale Contre le Cancer (équipe labelisée 2009). This letter is dedicated to Sabrina Dupont whose work greatly contributed to the discovery of TET2 mutations in MPNs. Funding Information: This work was supported by Bundesministerium für Bildung und Forschung grant NGFNplus 01GS0878.

PY - 2010/8

Y1 - 2010/8

UR - https://www.scopus.com/pages/publications/77955710421

U2 - 10.1038/leu.2010.122

DO - 10.1038/leu.2010.122

M3 - Letters

C2 - 20520641

AN - SCOPUS:77955710421

SN - 0887-6924

VL - 24

SP - 1523

EP - 1525

JO - Leukemia

JF - Leukemia

IS - 8

ER -